CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 8 of 14

Lupus

Briefs 281–320 of 555 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus

All coverage, newest first

  1. Lupus

    Evaluating the impact of type 2 diabetes mellitus on interstitial lung disease prevalence in patients with systemic lupus erythematosus: A national inpatient sample analysis

    Cohort studyLupus & APS

  2. Lupus

    Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India

    Cohort studyLupus & APS

  3. Lupus

    Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study

    Cohort studyLupus & APS

  4. Lupus

    Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus_PRO version 1.7

    Diagnostic or prognostic studyLupus & APS

  5. Lupus

    Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review

    Research articleLupus & APS

  6. Lupus

    Treatment adherence and quality of life in colombian patients with lupus nephritis

    Cross-sectional studyLupus & APS

  7. Lupus

    Needs for discharge planning and facilitators-barriers to implementing discharge plans for patients with SLE: A qualitative study

    Research articleLupus & APS

  8. Lupus

    Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  9. Lupus

    Genetic susceptibility and clinical features of CYP2D6 associated with systemic lupus erythematosus in a Chinese population

    Cohort studyLupus & APS

  10. Lupus

    The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective

    Research articleLupus & APS

  11. Lupus

    Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome

    Cohort studyLupus & APS

  12. Lupus

    Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study

    Cross-sectional studyLupus & APS

  13. Lupus

    Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue

    Cross-sectional studyLupus & APS

  14. Lupus

    Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study

    Case-control studyLupus & APS

  15. Lupus

    Alterations of the microbiome across body sites in systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  16. Lupus

    Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients

    Cohort studyLupus & APS

  17. Lupus

    Characteristics and outcomes of biopsy-proven lupus nephritis in the Eastern Cape province of South Africa

    Cohort studyLupus & APS

  18. Lupus

    Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it

    Cross-sectional studyLupus & APS

  19. Lupus

    Using linked electronic medical record-pharmacy data to examine lupus medication adherence: A retrospective cohort study

    Cohort studyLupus & APS

  20. Lupus

    Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions

    Cohort studyLupus & APS

  21. Lupus

    Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study

    Cohort studyPediatric

  22. Lupus

    Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis

    Diagnostic or prognostic studyLupus & APS

  23. Lupus

    Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  24. Lupus

    Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients

    Case-control studyLupus & APS

  25. Lupus

    Study of electrocardiographic corrected QT interval and QT dispersion abnormalities, erythrocyte sedimentation rate, serum uric acid in patients with systemic lupus erythematosus

    Case-control studyLupus & APS

  26. Lupus

    Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls

    Cross-sectional studyLupus & APS

  27. Lupus

    Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus

    Cohort studyLupus & APS

  28. Lupus

    Treatment patterns in patients with systemic lupus erythematosus in New Zealand

    Cross-sectional studyLupus & APS

  29. Lupus

    Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus

    Case-control studyLupus & APS

  30. Lupus

    Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus

    Cohort studyLupus & APS

  31. Lupus

    Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness

    Cohort studyLupus & APS

  32. Lupus

    Seroprevalence of Toxoplasma gondii immunoglobulins and its association with systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysisLupus & APS

  33. Lupus

    Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis

    Cross-sectional study

  34. Lupus

    Investigating physical inactivity and associated health parameters in patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  35. Lupus

    LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis

    Diagnostic or prognostic studyLupus & APS

  36. Lupus

    Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII

    Cohort studyLupus & APS

  37. Lupus

    Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients

    Cohort studyLupus & APS

  38. Lupus

    Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study

    Cohort studyLupus & APS

  39. Lupus

    Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus

    Case-control studyLupus & APS

  40. Lupus

    A qualitative investigation of the experiences of patients living with antiphospholipid antibodies

    Research articleLupus & APS

All 555 Briefs in ExploreShowing Briefs 281–320 of 555, newest first